🇩🇪 Rimegepant 75mg daily dosing in Germany

Rimegepant 75mg daily dosing (rimegepant-75mg-daily-dosing) regulatory status in Germany.

Marketing authorisation

BfArM

  • Status: approved

Rimegepant 75mg daily dosing in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Germany

Frequently asked questions

Is Rimegepant 75mg daily dosing approved in Germany?

Yes. BfArM has authorised it.

Who is the marketing authorisation holder for Rimegepant 75mg daily dosing in Germany?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.